Adolescent Fibromyalgia Study
Launched by PFIZER'S UPJOHN HAS MERGED WITH MYLAN TO FORM VIATRIS INC. · Nov 23, 2009
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of fibromyalgia
- • 12-17 years of age
- Exclusion Criteria:
- • Patients with other pain conditions
- • Previous treatment with pregabalin
- • Patients taking excluded medication
About Pfizer's Upjohn Has Merged With Mylan To Form Viatris Inc.
Viatris Inc. is a global healthcare company formed from the merger of Pfizer's Upjohn division and Mylan, dedicated to providing access to high-quality medicines, including generics and specialty pharmaceuticals. With a strong commitment to innovation and patient-centric solutions, Viatris leverages a diverse portfolio and extensive global reach to address the evolving healthcare needs of patients worldwide. The company aims to create sustainable healthcare solutions by combining expertise in pharmaceutical development, manufacturing, and distribution, ultimately enhancing patient outcomes and improving overall health systems.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Charleston, South Carolina, United States
Los Angeles, California, United States
Cincinnati, Ohio, United States
Louisville, Kentucky, United States
Columbus, Ohio, United States
Louisville, Kentucky, United States
Delray Beach, Florida, United States
Santa Ana, California, United States
Taipei, , Taiwan
Taipei, , Taiwan
Delray Beach, Florida, United States
Akron, Ohio, United States
Louisville, Kentucky, United States
Columbus, Ohio, United States
Orlando, Florida, United States
Salt Lake City, Utah, United States
Delray Beach, Florida, United States
Miami, Florida, United States
North Miami Beach, Florida, United States
Columbus, Georgia, United States
Lawrenceville, Georgia, United States
Louisville, Kentucky, United States
Worcester, Massachusetts, United States
Saint Louis, Missouri, United States
Durham, North Carolina, United States
Raleigh, North Carolina, United States
Boardman, Ohio, United States
Boardman, Ohio, United States
Philadelphia, Pennsylvania, United States
Charleston, South Carolina, United States
Charleston, South Carolina, United States
Myrtle Beach, South Carolina, United States
Ricany, , Czechia
Secunderabad, Andhra Pradesh, India
Mangalore, Karnataka, India
Nagpur, Maharashtra, India
Lucknow, Uttar Pradesh, India
Patients applied
Trial Officials
Pfizer CT.gov Call Center
Study Director
Pfizer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials